Computational Biology Market Size, Share, Top Key Players, Growth, Trend and Forecast Till 2026

Wide application of computational biology in genomics, epigenomics, proteomics, and meta-genomics to understand 3D protein structural analysis, protein-protein interactions, and gene sequencing and expression along with increasing R&D in drug designing and disease modeling are key factors contributing to high CAGR of Computational Biology during the forecast period.
Market Size – USD 28.68 billion in 2018, Market Growth - CAGR of 21.7%, Market Trends –technological advancements, research and development of advanced computational tools
According to the current analysis of Reports and Data, the global Computational Biology market was valued at USD 2.86 billion in 2018 and is expected to reach USD 13.77 billion by the year 2026, at a CAGR of 21.7%. Science is massively benefitted from data processing, such as computational biology. Computational biology is an interdisciplinary field of biology that applies computational methods for analyzing biological data, such as genetic sequences, cell populations, and protein samples, to discover new predictions. The computational techniques used in computational biology include analytical methods, mathematical modeling, and simulation. Moreover, new technologies such as sequencing, and high-throughput experimental methods like microarray, yeast two-hybrid, and chip-chip assays are creating enormous and increasing amounts of data that can be analyzed and processed effectively and hassle-free using computational techniques.
The drive-in technological advancements have now opened the door to a world of innovation in the field of healthcare. Computational genetics is disciplinary of computational biology where homology and internal biological mechanism are studied using genome sequencing. The Human Genome Project is a classic example where the whole human genome was sequenced successfully. Computational biology also finds application in neurology, in which it is used to map complex interlinked pathways to visualize 3D simulation models of the brain. The medical advantage of computational biology is anticipated to boost the market during the forecast period. Additionally, computational pharmacology also uses tools of computational biology to visualize and simulate advanced drug-drug interactions in the drug designing process.

Key companies profiled in the report include
Chemical Computing Group, Compugen, Simulation Plus, Genedata, Certara, Insilico Biotechnology, Accelrys, Rhenovia Pharma, Entelos, Nimbus Discovery, and Rhenovia Pharma

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2247

The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the Computational Biology market.
The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2247

The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.

The key geographical regions analyzed in the market report are:
• North America (U.S.A., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Computational Biology Market Segmentation based on Types:
Service Type (Revenue, USD Million; 2016–2026)
• In-house
• Contract

Application Type (Revenue, USD Million; 2016–2026)
• Cellular & Biology Simulation
o Computational Genomics
 Database
 Infrastructure / Hardware
 Software & Services
o Computational Proteomics
o Pharmacogenomics
o Others
• Drug discovery and disease modeling
o Target identification
o Target Validation
o Lead Discovery
o Lead Optimization
• Pre-clinical drug development
o Pharmacokinetics
o Pharmacodynamics
• Clinical trials
o Phase I
o Phase II
o Phase III
• Human Body Simulation Software

End Use (Revenue, USD Million; 2016–2026)
• Academics
• Industry
• Commercial

To know more about the report @ https://www.reportsanddata.com/report-detail/computational-biology-market

Further key findings from the report suggest
• Computational Biology market is growing at a CAGR of 2% in Asia-Pacific due to owing to increased spending on research works in pharmacogenomics and pharmacokinetics in clinical studies for new drugs in the region.
• In-house services are expected to be the fastest growing service segment during the forecast period 2019-2026. Several funding and R&D initiatives are undertaken by private institutions, and biopharmaceutical companies for the detection of a biomarker for drug development and disorder are driving the market growth.
• North America region accounted for nearly 45% of the market share in 2018 owing to increasing R&D activities for drug discovery processes and development of new biological computation tools.
• Several funding and R&D initiatives are undertaken by private institutions, and biopharmaceutical companies for the detection of a biomarker for drug development and disorder are driving the market growth.
• Computational Genomics segment is expected to witness lucrative growth attributing to the recent technological advancements in cloud computing and other IT technologies. For instance, the Epidemiology and Genomics Research Program (EGRP) grants endowment to research-related activities and related need for personalization in healthcare owing to genetic variations, expanding application in non-oncology diseases,
• Market players are adapting various organic and inorganic expansion strategies. For instance, Paragon Genomics Introduces CleanPlex CFTR Panel and unveils new fusion detection enables identification of known and novel gene fusions as diagnostic and prognostic markers for tumor progression. The CFTR Panel leverages Paragon Genomics' CleanPlex technology in a multiplex PCR-based targeted resequencing assay designed to simplify the evaluation of somatic and germline variants across the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene.
• Bioinformatics expanded to the development and the use of computational tools for the biological interpretation of the large amounts of data. There is a very heterogeneous scientific community that covers all aspects of today’s genetic research. In the coming years the commitment to bioinformatics and system biology will be extended even further with increased funding and explicit commitment to both of these areas.
• Recently, in November 2019, Alibaba funded Hong Kong biotech firms to boost investments. The fund has invested in Hong Kong-based Prenetics, which provides genetics testing solutions for cancer screening and pharmacogenomics

Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/2247

Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.

Browse More Reports:

Casting and Splinting Market @ https://www.google.nu/url?q=https://www.reportsanddata.com/report-detail/casting-and-splinting-market

Adenosine Deaminase Deficiency Market @ https://www.google.ga/url?q=https://www.reportsanddata.com/report-detail/adenosine-deaminase-deficiency-market

Facial Erythema Therapeutics Market @ https://www.google.hu/url?q=https://www.reportsanddata.com/report-detail/facial-erythema-therapeutics-market

Carotid Stents System Market @ https://www.google.com.ua/url?q=https://www.reportsanddata.com/report-detail/carotid-stents-system-market

Sodium Bicarbonate Injection Market @ https://www.google.cl/url?q=https://www.reportsanddata.com/report-detail/sodium-bicarbonate-injection-market

Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.